M
Modifyhealth
Helps bring relief to patients suffering from conditions where dietary modification is a recommended treatment
About Modifyhealth
ModifyHealth operates as a "food as medicine" platform, providing medically tailored meals and virtual nutrition support for individuals with chronic health conditions. The company focuses on conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), celiac disease, diabetes, and cardiovascular issues, where dietary modification is a key component of management.
Its business model combines direct-to-consumer meal delivery subscriptions with a B2B2C strategy that involves partnerships with healthcare providers and GI practices. Clinicians can refer their patients to ModifyHealth, integrating the service into their treatment plans. The company generates revenue through the sale of these meal plans and potentially through its virtual dietitian and health coaching services. This approach leverages medical endorsements to acquire customers, aiming for higher retention rates than typical consumer-driven meal kit services.
The company offers a range of specialized meal plans, including Low-FODMAP, gluten-free, and Mediterranean diets, which are prepared and delivered to the customer's home. Beyond meals, ModifyHealth provides a digital health platform that includes access to registered dietitians for coaching and support, remote patient monitoring, and tracking of clinical metrics, which can be integrated with Electronic Medical Records (EMR).
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Alpharetta, United States
- Employees
- 107
- Open positions
- None listed
- Dealroom signal
- 92.6/100
- Industry
- Health, Food
- Sub-industry
- Health Platform, Food Logistics & Delivery
- Sector
- Health Tech & Medtech, Dietary Supplements, Superfood, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Dec 2024 | $14M | $54M | RC Capital · Dohmen · Nashville Capital Network | ↗ |
| SERIES B✓Equity / VC | Jan 2023 | $10M | $40M | Nashville Capital Network · RC Capital | ↗ |
Growth signals
Latest recorded traffic for Modifyhealth is 140K monthly website visits, up 0% over the last three months. Modifyhealth's team grew 21.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Nashville Capital Network
RC Capital
Series B and later1 investor entered at this stage
Dohmen
Other known investors1 additional known investor
Middleland Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Modifyhealth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Modifyhealth’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







